Wolverine Stack

The Wolverine stack is the name the recovery community gives to BPC-157 and TB-500 used together. It is named after the comic-book hero who heals from anything, and it has become one of the most talked-about pairings in the peptide world.

The appeal is easy to see. BPC-157 is a 15-amino-acid fragment of a protective protein found in gastric juice, and in animal studies it has been linked to better healing of tendon, ligament, muscle and bone injuries. TB-500 is a short fragment of thymosin beta-4, a natural protein that helps cells move to where repair is needed. People pair them because they appear to work on different parts of the repair process.

What the research says: each peptide has a real preclinical story. A 2025 systematic review in HSS Journal found 35 preclinical studies and one small clinical report on BPC-157, with improved functional and structural healing in animal muscle, tendon, ligament and bone injury models, and no clinical safety data yet. Thymosin beta-4 has been studied in wound, eye and heart repair models. The stack itself has not been tested in a published human trial, so its reputation comes from the science behind each part plus a lot of real-world enthusiasm.

Status check: neither peptide is FDA-approved. On FDA's compounding safety page, BPC-157 and TB-500 now sit on the "nominated but withdrawn" list rather than in Category 2, which does not make them approved drugs. Both are prohibited in sport under the WADA Prohibited List. If you are curious, bring it to a clinician who knows your history.